Rank | Gene Set | Z-score |
---|---|---|
1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 6.90705012 |
2 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 5.80957092 |
3 | ATP synthesis coupled proton transport (GO:0015986) | 5.80957092 |
4 | proteasome assembly (GO:0043248) | 5.34586577 |
5 | ribosomal small subunit biogenesis (GO:0042274) | 4.91747381 |
6 | viral transcription (GO:0019083) | 4.73919941 |
7 | respiratory electron transport chain (GO:0022904) | 4.68014399 |
8 | translational termination (GO:0006415) | 4.54789928 |
9 | electron transport chain (GO:0022900) | 4.54690849 |
10 | chaperone-mediated protein transport (GO:0072321) | 4.50671573 |
11 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.49822134 |
12 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.47599087 |
13 | protein targeting to ER (GO:0045047) | 4.46723133 |
14 | cotranslational protein targeting to membrane (GO:0006613) | 4.43526889 |
15 | ribosomal large subunit biogenesis (GO:0042273) | 4.38321285 |
16 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.29247231 |
17 | protein localization to endoplasmic reticulum (GO:0070972) | 4.25397182 |
18 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.21645571 |
19 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.18258208 |
20 | negative regulation of ligase activity (GO:0051352) | 3.96554921 |
21 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.96554921 |
22 | ribosomal small subunit assembly (GO:0000028) | 3.93758416 |
23 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.89595283 |
24 | maturation of SSU-rRNA (GO:0030490) | 3.86428608 |
25 | translational elongation (GO:0006414) | 3.84918516 |
26 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.81605699 |
27 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.73706725 |
28 | viral life cycle (GO:0019058) | 3.71277838 |
29 | regulation of chronic inflammatory response (GO:0002676) | 3.70149940 |
30 | translation (GO:0006412) | 3.69918792 |
31 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.68725262 |
32 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.60847304 |
33 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.58668040 |
34 | translational initiation (GO:0006413) | 3.55776836 |
35 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.53351017 |
36 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.53351017 |
37 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.51104548 |
38 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.51104548 |
39 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.51104548 |
40 | establishment of viral latency (GO:0019043) | 3.49280197 |
41 | purine nucleotide salvage (GO:0032261) | 3.49241655 |
42 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.47114779 |
43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.46930346 |
44 | cellular protein complex disassembly (GO:0043624) | 3.46586666 |
45 | establishment of integrated proviral latency (GO:0075713) | 3.46358617 |
46 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.41700751 |
47 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.41700751 |
48 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.38320546 |
49 | regulation of mitochondrial translation (GO:0070129) | 3.34986249 |
50 | protein neddylation (GO:0045116) | 3.33908325 |
51 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.33659665 |
52 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 3.31290451 |
53 | protein targeting to mitochondrion (GO:0006626) | 3.25465435 |
54 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.22648737 |
55 | protein complex biogenesis (GO:0070271) | 3.21737733 |
56 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.21475068 |
57 | positive regulation of ligase activity (GO:0051351) | 3.19462887 |
58 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 3.16314146 |
59 | regulation of vitamin metabolic process (GO:0030656) | 3.12678696 |
60 | hydrogen ion transmembrane transport (GO:1902600) | 3.08928070 |
61 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.07381937 |
62 | rRNA modification (GO:0000154) | 3.04751142 |
63 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.04720075 |
64 | termination of RNA polymerase III transcription (GO:0006386) | 3.04720075 |
65 | ATP biosynthetic process (GO:0006754) | 3.02761097 |
66 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.00041899 |
67 | cellular component biogenesis (GO:0044085) | 2.99959784 |
68 | protein targeting to membrane (GO:0006612) | 2.99389641 |
69 | establishment of protein localization to mitochondrion (GO:0072655) | 2.99210796 |
70 | protein localization to mitochondrion (GO:0070585) | 2.98533371 |
71 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 2.95763836 |
72 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.93149033 |
73 | NADH dehydrogenase complex assembly (GO:0010257) | 2.93149033 |
74 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.93149033 |
75 | regulation of ligase activity (GO:0051340) | 2.91443156 |
76 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 2.89035554 |
77 | purine nucleobase biosynthetic process (GO:0009113) | 2.88915433 |
78 | oxidative phosphorylation (GO:0006119) | 2.88418138 |
79 | regulation of podosome assembly (GO:0071801) | 2.83695357 |
80 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.82180634 |
81 | rRNA processing (GO:0006364) | 2.80257061 |
82 | negative regulation of protein ubiquitination (GO:0031397) | 2.80020302 |
83 | regulation of cellular amine metabolic process (GO:0033238) | 2.79923043 |
84 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.78841944 |
85 | protein complex disassembly (GO:0043241) | 2.78834354 |
86 | nucleotide salvage (GO:0043173) | 2.77275466 |
87 | spliceosomal snRNP assembly (GO:0000387) | 2.74024144 |
88 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.73159844 |
89 | nucleoside salvage (GO:0043174) | 2.71983915 |
90 | macromolecular complex disassembly (GO:0032984) | 2.70173418 |
91 | cellular response to zinc ion (GO:0071294) | 2.68204574 |
92 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.67828237 |
93 | mitochondrial transport (GO:0006839) | 2.66754512 |
94 | negative regulation of protein modification by small protein conjugation or removal (GO:1903321) | 2.65955578 |
95 | rRNA metabolic process (GO:0016072) | 2.65863209 |
96 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.65827819 |
97 | purine-containing compound salvage (GO:0043101) | 2.65225046 |
98 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.63951605 |
99 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.63951605 |
100 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.63002066 |
Rank | Gene Set | Z-score |
---|---|---|
1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.91798649 |
2 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 4.31268625 |
3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.04242082 |
4 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.85349537 |
5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.67844715 |
6 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.65214771 |
7 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.47541298 |
8 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.19226587 |
9 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.17079654 |
10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.94458580 |
11 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.88551269 |
12 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.77308490 |
13 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.74494468 |
14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.63401534 |
15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.59186065 |
16 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.59075956 |
17 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.56707783 |
18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.50775414 |
19 | DCP1A_22483619_ChIP-Seq_HELA_Human | 2.50698290 |
20 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.46431396 |
21 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.36646446 |
22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.23156118 |
23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.19492624 |
24 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.16502968 |
25 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.15868673 |
26 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.12935136 |
27 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.12557097 |
28 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.12245898 |
29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.12224699 |
30 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.09727399 |
31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.05032437 |
32 | * XRN2_22483619_ChIP-Seq_HELA_Human | 2.02511900 |
33 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.93247933 |
34 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.92778778 |
35 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.86051574 |
36 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.79059691 |
37 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.77749835 |
38 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.77405502 |
39 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.76387852 |
40 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.74717296 |
41 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.74681973 |
42 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.71855754 |
43 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.70819655 |
44 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.69709873 |
45 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.66824493 |
46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.60182371 |
47 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.59875312 |
48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.56770229 |
49 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.55421512 |
50 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.54113283 |
51 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.51853012 |
52 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.50551558 |
53 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.49417759 |
54 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.49096290 |
55 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.46129923 |
56 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44822350 |
57 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.44729597 |
58 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42182172 |
59 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.41708167 |
60 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.39016875 |
61 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.38408838 |
62 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.34117524 |
63 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.32828343 |
64 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.32417695 |
65 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.32099844 |
66 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.25941256 |
67 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.25765156 |
68 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.24611672 |
69 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.23399425 |
70 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.21373392 |
71 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.18465066 |
72 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18151902 |
73 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16380055 |
74 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.14852353 |
75 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.14342007 |
76 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.14052607 |
77 | ELF5_23300383_ChIP-Seq_T47D_Human | 1.12992903 |
78 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12130601 |
79 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.12129581 |
80 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11543885 |
81 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.11184644 |
82 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.09859468 |
83 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.05743650 |
84 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.05595358 |
85 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.04168424 |
86 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.00480740 |
87 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.99588412 |
88 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.99049702 |
89 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.98857553 |
90 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.96100387 |
91 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.95736538 |
92 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.95413123 |
93 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.89279238 |
94 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.89236716 |
95 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.87995050 |
96 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.87059676 |
97 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.86929644 |
98 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.83690355 |
99 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.83522902 |
100 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.82142505 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003806_abnormal_nucleotide_metabolis | 7.25476535 |
2 | MP0002148_abnormal_hypersensitivity_rea | 3.58674348 |
3 | MP0003186_abnormal_redox_activity | 3.39658612 |
4 | MP0003303_peritoneal_inflammation | 3.21999702 |
5 | MP0002139_abnormal_hepatobiliary_system | 3.04876692 |
6 | MP0009785_altered_susceptibility_to | 2.93395736 |
7 | MP0006082_CNS_inflammation | 2.88790124 |
8 | MP0009379_abnormal_foot_pigmentation | 2.78398752 |
9 | MP0001853_heart_inflammation | 2.68386654 |
10 | MP0005058_abnormal_lysosome_morphology | 2.50436754 |
11 | MP0004957_abnormal_blastocyst_morpholog | 2.24259149 |
12 | MP0003941_abnormal_skin_development | 2.23215014 |
13 | MP0000343_altered_response_to | 2.22153421 |
14 | MP0004510_myositis | 2.20877253 |
15 | MP0003693_abnormal_embryo_hatching | 2.18972514 |
16 | MP0001835_abnormal_antigen_presentation | 2.06929583 |
17 | MP0009764_decreased_sensitivity_to | 2.00755550 |
18 | MP0009697_abnormal_copulation | 1.94065483 |
19 | MP0006036_abnormal_mitochondrial_physio | 1.93056367 |
20 | MP0008007_abnormal_cellular_replicative | 1.79387194 |
21 | MP0008058_abnormal_DNA_repair | 1.73032421 |
22 | MP0003075_altered_response_to | 1.69129340 |
23 | MP0010094_abnormal_chromosome_stability | 1.67967813 |
24 | MP0003111_abnormal_nucleus_morphology | 1.66087381 |
25 | MP0005671_abnormal_response_to | 1.65653624 |
26 | MP0009840_abnormal_foam_cell | 1.63135231 |
27 | MP0003077_abnormal_cell_cycle | 1.62099098 |
28 | MP0005000_abnormal_immune_tolerance | 1.60681472 |
29 | MP0009333_abnormal_splenocyte_physiolog | 1.60193261 |
30 | MP0003453_abnormal_keratinocyte_physiol | 1.58927246 |
31 | MP0005025_abnormal_response_to | 1.56232588 |
32 | MP0003950_abnormal_plasma_membrane | 1.52934247 |
33 | MP0001790_abnormal_immune_system | 1.52213951 |
34 | MP0005387_immune_system_phenotype | 1.52213951 |
35 | MP0002877_abnormal_melanocyte_morpholog | 1.49169472 |
36 | MP0008469_abnormal_protein_level | 1.47593524 |
37 | MP0005451_abnormal_body_composition | 1.46057908 |
38 | MP0000858_altered_metastatic_potential | 1.45536247 |
39 | MP0003718_maternal_effect | 1.45158992 |
40 | MP0001542_abnormal_bone_strength | 1.44877446 |
41 | MP0005408_hypopigmentation | 1.44856693 |
42 | MP0003448_altered_tumor_morphology | 1.42652357 |
43 | MP0003436_decreased_susceptibility_to | 1.42417686 |
44 | MP0008875_abnormal_xenobiotic_pharmacok | 1.41567756 |
45 | MP0001845_abnormal_inflammatory_respons | 1.41520442 |
46 | MP0006054_spinal_hemorrhage | 1.40762375 |
47 | MP0002452_abnormal_antigen_presenting | 1.38852679 |
48 | MP0002419_abnormal_innate_immunity | 1.35448852 |
49 | MP0001764_abnormal_homeostasis | 1.33475158 |
50 | MP0000358_abnormal_cell_content/ | 1.21622067 |
51 | MP0002723_abnormal_immune_serum | 1.20126036 |
52 | MP0006035_abnormal_mitochondrial_morpho | 1.19702550 |
53 | MP0008932_abnormal_embryonic_tissue | 1.18659764 |
54 | MP0008004_abnormal_stomach_pH | 1.13306279 |
55 | MP0005165_increased_susceptibility_to | 1.12767158 |
56 | MP0004947_skin_inflammation | 1.10230048 |
57 | MP0009765_abnormal_xenobiotic_induced | 1.08587476 |
58 | MP0003724_increased_susceptibility_to | 1.08524065 |
59 | MP0002254_reproductive_system_inflammat | 1.07828037 |
60 | MP0005166_decreased_susceptibility_to | 1.07406631 |
61 | MP0000685_abnormal_immune_system | 1.06958979 |
62 | MP0003191_abnormal_cellular_cholesterol | 1.06930313 |
63 | MP0010155_abnormal_intestine_physiology | 1.06531511 |
64 | MP0003786_premature_aging | 1.05701266 |
65 | MP0000490_abnormal_crypts_of | 1.03302055 |
66 | MP0001727_abnormal_embryo_implantation | 1.00910707 |
67 | MP0001800_abnormal_humoral_immune | 1.00499201 |
68 | MP0002332_abnormal_exercise_endurance | 1.00444063 |
69 | MP0005266_abnormal_metabolism | 1.00428534 |
70 | MP0009763_increased_sensitivity_to | 1.00084497 |
71 | MP0001881_abnormal_mammary_gland | 0.98717900 |
72 | MP0005319_abnormal_enzyme/_coenzyme | 0.97903534 |
73 | MP0001533_abnormal_skeleton_physiology | 0.96076266 |
74 | MP0005310_abnormal_salivary_gland | 0.95932824 |
75 | MP0002277_abnormal_respiratory_mucosa | 0.94422666 |
76 | MP0003656_abnormal_erythrocyte_physiolo | 0.94331669 |
77 | MP0002938_white_spotting | 0.93804417 |
78 | MP0003195_calcinosis | 0.92805259 |
79 | MP0002405_respiratory_system_inflammati | 0.91910430 |
80 | MP0001819_abnormal_immune_cell | 0.90824396 |
81 | MP0000313_abnormal_cell_death | 0.90077129 |
82 | MP0002420_abnormal_adaptive_immunity | 0.86500882 |
83 | MP0008873_increased_physiological_sensi | 0.86178534 |
84 | MP0005397_hematopoietic_system_phenotyp | 0.85715228 |
85 | MP0001545_abnormal_hematopoietic_system | 0.85715228 |
86 | MP0001216_abnormal_epidermal_layer | 0.84834409 |
87 | MP0010307_abnormal_tumor_latency | 0.82638833 |
88 | MP0002837_dystrophic_cardiac_calcinosis | 0.80747034 |
89 | MP0000350_abnormal_cell_proliferation | 0.79433851 |
90 | MP0002163_abnormal_gland_morphology | 0.79075124 |
91 | MP0002796_impaired_skin_barrier | 0.78242482 |
92 | MP0005636_abnormal_mineral_homeostasis | 0.75001377 |
93 | MP0002019_abnormal_tumor_incidence | 0.74167632 |
94 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.72187300 |
95 | MP0005164_abnormal_response_to | 0.71712179 |
96 | MP0003315_abnormal_perineum_morphology | 0.70830687 |
97 | MP0002090_abnormal_vision | 0.69513416 |
98 | MP0000372_irregular_coat_pigmentation | 0.68747874 |
99 | MP0005501_abnormal_skin_physiology | 0.68683915 |
100 | MP0005376_homeostasis/metabolism_phenot | 0.67184776 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Acute necrotizing encephalopathy (HP:0006965) | 5.48190105 |
2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 5.18941658 |
3 | Mitochondrial inheritance (HP:0001427) | 4.92032707 |
4 | Increased hepatocellular lipid droplets (HP:0006565) | 4.81715060 |
5 | Acute encephalopathy (HP:0006846) | 4.71839407 |
6 | Increased CSF lactate (HP:0002490) | 4.46205680 |
7 | Progressive macrocephaly (HP:0004481) | 4.41225681 |
8 | Renal Fanconi syndrome (HP:0001994) | 4.41017041 |
9 | Lipid accumulation in hepatocytes (HP:0006561) | 4.39474312 |
10 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 4.14996818 |
11 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 4.14996818 |
12 | Hepatocellular necrosis (HP:0001404) | 4.14417525 |
13 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.00066733 |
14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.00066733 |
15 | Abnormality of glycolipid metabolism (HP:0010969) | 4.00066733 |
16 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.96840925 |
17 | 3-Methylglutaconic aciduria (HP:0003535) | 3.86159772 |
18 | Hepatic necrosis (HP:0002605) | 3.82949862 |
19 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.81617502 |
20 | Macrocytic anemia (HP:0001972) | 3.79707741 |
21 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.67062294 |
22 | Increased intramyocellular lipid droplets (HP:0012240) | 3.66715925 |
23 | Cerebral edema (HP:0002181) | 3.61186324 |
24 | Abnormal number of erythroid precursors (HP:0012131) | 3.57207759 |
25 | Generalized aminoaciduria (HP:0002909) | 3.55635378 |
26 | Oral leukoplakia (HP:0002745) | 3.55488454 |
27 | Reticulocytopenia (HP:0001896) | 3.34173246 |
28 | Exertional dyspnea (HP:0002875) | 3.33546703 |
29 | Respiratory failure (HP:0002878) | 3.15173473 |
30 | Aplastic anemia (HP:0001915) | 3.08488913 |
31 | Vacuolated lymphocytes (HP:0001922) | 3.07472064 |
32 | Increased muscle lipid content (HP:0009058) | 3.06189032 |
33 | Lactic acidosis (HP:0003128) | 2.98379960 |
34 | Nausea (HP:0002018) | 2.97827886 |
35 | Type I transferrin isoform profile (HP:0003642) | 2.96915672 |
36 | Increased serum lactate (HP:0002151) | 2.92616266 |
37 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.90078762 |
38 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.89823117 |
39 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.84903481 |
40 | Parakeratosis (HP:0001036) | 2.82488987 |
41 | Exercise intolerance (HP:0003546) | 2.81699688 |
42 | Respiratory difficulties (HP:0002880) | 2.81579886 |
43 | Amniotic constriction ring (HP:0009775) | 2.81463703 |
44 | Abnormality of placental membranes (HP:0011409) | 2.81463703 |
45 | Rough bone trabeculation (HP:0100670) | 2.78897166 |
46 | Reduced antithrombin III activity (HP:0001976) | 2.74661455 |
47 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.71010078 |
48 | Abnormality of renal resorption (HP:0011038) | 2.69901287 |
49 | Pallor (HP:0000980) | 2.69263345 |
50 | Sparse eyelashes (HP:0000653) | 2.59166803 |
51 | Congenital, generalized hypertrichosis (HP:0004540) | 2.56607139 |
52 | Abnormal trabecular bone morphology (HP:0100671) | 2.55979193 |
53 | Degeneration of anterior horn cells (HP:0002398) | 2.47312176 |
54 | Abnormality of the anterior horn cell (HP:0006802) | 2.47312176 |
55 | Leukodystrophy (HP:0002415) | 2.47013860 |
56 | Multiple enchondromatosis (HP:0005701) | 2.43930766 |
57 | Abnormality of methionine metabolism (HP:0010901) | 2.41490197 |
58 | Increased serum pyruvate (HP:0003542) | 2.41250611 |
59 | Nuclear cataract (HP:0100018) | 2.37917662 |
60 | Disinhibition (HP:0000734) | 2.36733549 |
61 | Systemic lupus erythematosus (HP:0002725) | 2.27856651 |
62 | Lethargy (HP:0001254) | 2.27256685 |
63 | Abnormality of glycolysis (HP:0004366) | 2.22245714 |
64 | Loss of speech (HP:0002371) | 2.21363968 |
65 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.19702560 |
66 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.19702560 |
67 | Abnormal protein glycosylation (HP:0012346) | 2.19702560 |
68 | Abnormal glycosylation (HP:0012345) | 2.19702560 |
69 | Hepatosplenomegaly (HP:0001433) | 2.13199473 |
70 | CNS demyelination (HP:0007305) | 2.10139281 |
71 | Mutism (HP:0002300) | 2.07859201 |
72 | Poor head control (HP:0002421) | 2.06520181 |
73 | Microvesicular hepatic steatosis (HP:0001414) | 2.02707599 |
74 | Optic disc pallor (HP:0000543) | 2.02238543 |
75 | Pancytopenia (HP:0001876) | 1.99494703 |
76 | Axonal loss (HP:0003447) | 1.99250862 |
77 | Neoplasm of head and neck (HP:0012288) | 1.93866406 |
78 | Esophageal neoplasm (HP:0100751) | 1.93866406 |
79 | Testicular atrophy (HP:0000029) | 1.92938335 |
80 | Hypertensive crisis (HP:0100735) | 1.92862038 |
81 | Glycosuria (HP:0003076) | 1.92361523 |
82 | Abnormality of urine glucose concentration (HP:0011016) | 1.92361523 |
83 | Increased serum ferritin (HP:0003281) | 1.91654975 |
84 | Autoimmune thrombocytopenia (HP:0001973) | 1.84732104 |
85 | Paralysis (HP:0003470) | 1.83648002 |
86 | Emotional lability (HP:0000712) | 1.81142125 |
87 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.80886972 |
88 | X-linked dominant inheritance (HP:0001423) | 1.80711019 |
89 | Hyperphosphaturia (HP:0003109) | 1.79877653 |
90 | Prolonged neonatal jaundice (HP:0006579) | 1.78764323 |
91 | Increased IgM level (HP:0003496) | 1.78484756 |
92 | Progressive neurologic deterioration (HP:0002344) | 1.76879787 |
93 | Fasciculations (HP:0002380) | 1.76597267 |
94 | Vomiting (HP:0002013) | 1.71028693 |
95 | Methylmalonic aciduria (HP:0012120) | 1.69891075 |
96 | Petechiae (HP:0000967) | 1.68872472 |
97 | Posterior subcapsular cataract (HP:0007787) | 1.66157729 |
98 | Abnormality of macrophages (HP:0004311) | 1.65241875 |
99 | Cleft eyelid (HP:0000625) | 1.64901812 |
100 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.62951962 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NME2 | 6.03939670 |
2 | VRK2 | 4.04379541 |
3 | IRAK3 | 3.41178451 |
4 | PBK | 3.35561889 |
5 | BUB1 | 3.10180292 |
6 | MAP3K12 | 2.95682798 |
7 | MST4 | 2.95671380 |
8 | STK16 | 2.87224880 |
9 | PIM2 | 2.56266605 |
10 | GRK7 | 2.52192981 |
11 | EIF2AK1 | 2.34023732 |
12 | NEK1 | 2.08846087 |
13 | TESK1 | 1.92541068 |
14 | SRPK1 | 1.91462997 |
15 | CDC7 | 1.81785015 |
16 | NME1 | 1.80818367 |
17 | ABL2 | 1.79420355 |
18 | TAOK2 | 1.78503830 |
19 | EIF2AK3 | 1.72359492 |
20 | PAK4 | 1.63174438 |
21 | VRK1 | 1.62348917 |
22 | TESK2 | 1.48617943 |
23 | ARAF | 1.39520920 |
24 | MST1R | 1.38562588 |
25 | LIMK1 | 1.34329116 |
26 | PDK2 | 1.29097290 |
27 | TBK1 | 1.27527482 |
28 | MATK | 1.26158299 |
29 | DDR2 | 1.26039610 |
30 | ADRBK2 | 1.24941863 |
31 | IKBKB | 1.12113619 |
32 | TTK | 1.10459986 |
33 | ZAK | 1.07833319 |
34 | MOS | 1.05711522 |
35 | TLK1 | 0.98313902 |
36 | CLK1 | 0.97860730 |
37 | PLK3 | 0.95765214 |
38 | TAF1 | 0.93651268 |
39 | MAP3K14 | 0.93274218 |
40 | MAP3K11 | 0.90487385 |
41 | MYLK | 0.90222219 |
42 | BCKDK | 0.89016005 |
43 | WEE1 | 0.88784000 |
44 | PLK4 | 0.86023364 |
45 | MAP3K3 | 0.85995873 |
46 | EIF2AK2 | 0.85701307 |
47 | ERBB4 | 0.84906664 |
48 | SCYL2 | 0.84552280 |
49 | DAPK1 | 0.83798602 |
50 | PLK1 | 0.83794885 |
51 | DAPK3 | 0.83460162 |
52 | DYRK3 | 0.83057853 |
53 | EPHA2 | 0.79988407 |
54 | LATS2 | 0.78808513 |
55 | BMPR2 | 0.76034746 |
56 | AURKB | 0.75658802 |
57 | AURKA | 0.72270004 |
58 | RPS6KB2 | 0.68057713 |
59 | STK10 | 0.68028805 |
60 | ILK | 0.66979987 |
61 | CHEK2 | 0.66662882 |
62 | TYK2 | 0.63008376 |
63 | CSNK1G3 | 0.61977508 |
64 | CCNB1 | 0.60504794 |
65 | CSNK2A1 | 0.58679142 |
66 | MKNK1 | 0.57283225 |
67 | BRSK2 | 0.56674775 |
68 | MAP3K5 | 0.55701053 |
69 | IKBKE | 0.55285266 |
70 | ACVR1B | 0.54396520 |
71 | CSNK2A2 | 0.54052506 |
72 | TAOK1 | 0.53390293 |
73 | PAK1 | 0.49055471 |
74 | CHUK | 0.48401566 |
75 | TSSK6 | 0.47418393 |
76 | NUAK1 | 0.44739855 |
77 | IRAK4 | 0.42244665 |
78 | CDK8 | 0.41377917 |
79 | MAPKAPK5 | 0.39800582 |
80 | MAP3K8 | 0.39226173 |
81 | KDR | 0.39071416 |
82 | TGFBR2 | 0.38814497 |
83 | CSNK1A1L | 0.37305968 |
84 | RPS6KA5 | 0.37177030 |
85 | STK4 | 0.36933281 |
86 | CDK14 | 0.36061623 |
87 | CAMK2G | 0.35818580 |
88 | BRAF | 0.34446645 |
89 | BRSK1 | 0.34364393 |
90 | DYRK2 | 0.33487489 |
91 | PRKCI | 0.33483971 |
92 | CSNK1G2 | 0.33341544 |
93 | PIM1 | 0.32418411 |
94 | CDK11A | 0.30091105 |
95 | FGR | 0.29759910 |
96 | CDK15 | 0.28991302 |
97 | ALK | 0.28955315 |
98 | CDK18 | 0.28627938 |
99 | CSNK1G1 | 0.28126928 |
100 | PRKG2 | 0.27874180 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 4.82366961 |
2 | Ribosome_Homo sapiens_hsa03010 | 4.59496933 |
3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.31026837 |
4 | Parkinsons disease_Homo sapiens_hsa05012 | 3.50447506 |
5 | Protein export_Homo sapiens_hsa03060 | 2.68557568 |
6 | DNA replication_Homo sapiens_hsa03030 | 2.48109298 |
7 | Huntingtons disease_Homo sapiens_hsa05016 | 2.41760088 |
8 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.39933336 |
9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.38752053 |
10 | Mismatch repair_Homo sapiens_hsa03430 | 2.32433269 |
11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.15874262 |
12 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.10875840 |
13 | RNA polymerase_Homo sapiens_hsa03020 | 2.06070851 |
14 | Homologous recombination_Homo sapiens_hsa03440 | 1.75969761 |
15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.71456721 |
16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.64863183 |
17 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.62547960 |
18 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.62448873 |
19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.60778976 |
20 | Spliceosome_Homo sapiens_hsa03040 | 1.59010197 |
21 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.51776725 |
22 | Asthma_Homo sapiens_hsa05310 | 1.47082411 |
23 | Allograft rejection_Homo sapiens_hsa05330 | 1.29055848 |
24 | Base excision repair_Homo sapiens_hsa03410 | 1.22081939 |
25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.13305057 |
26 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.12660758 |
27 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12533312 |
28 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.11264144 |
29 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.08970228 |
30 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.05732304 |
31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.03388105 |
32 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00948160 |
33 | Legionellosis_Homo sapiens_hsa05134 | 0.99757180 |
34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99648279 |
35 | Lysosome_Homo sapiens_hsa04142 | 0.96495026 |
36 | RNA transport_Homo sapiens_hsa03013 | 0.95561678 |
37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.95513870 |
38 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.93159643 |
39 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.92869083 |
40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.92026529 |
41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.88677282 |
42 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.84766021 |
43 | Other glycan degradation_Homo sapiens_hsa00511 | 0.84694748 |
44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.84634594 |
45 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.84239493 |
46 | Basal transcription factors_Homo sapiens_hsa03022 | 0.83450183 |
47 | Purine metabolism_Homo sapiens_hsa00230 | 0.82787801 |
48 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.80426607 |
49 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.79794495 |
50 | RNA degradation_Homo sapiens_hsa03018 | 0.79173283 |
51 | Salmonella infection_Homo sapiens_hsa05132 | 0.78691042 |
52 | Mineral absorption_Homo sapiens_hsa04978 | 0.78606356 |
53 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.78300921 |
54 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.77927286 |
55 | Pertussis_Homo sapiens_hsa05133 | 0.77064126 |
56 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.72070586 |
57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.69716242 |
58 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.69154910 |
59 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.67531615 |
60 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.66359141 |
61 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.65318198 |
62 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.64449791 |
63 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62953413 |
64 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62700071 |
65 | Metabolic pathways_Homo sapiens_hsa01100 | 0.61680957 |
66 | Malaria_Homo sapiens_hsa05144 | 0.61428375 |
67 | Cell cycle_Homo sapiens_hsa04110 | 0.59386128 |
68 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.59074817 |
69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.59017509 |
70 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.59017360 |
71 | Shigellosis_Homo sapiens_hsa05131 | 0.58495385 |
72 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.58030692 |
73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.55537170 |
74 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.54735273 |
75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.54018114 |
76 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.52205989 |
77 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.51853398 |
78 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.51539847 |
79 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.50025537 |
80 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.48718387 |
81 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.48359214 |
82 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.47984622 |
83 | Phagosome_Homo sapiens_hsa04145 | 0.46516701 |
84 | Influenza A_Homo sapiens_hsa05164 | 0.46317394 |
85 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44824448 |
86 | Leishmaniasis_Homo sapiens_hsa05140 | 0.44365896 |
87 | Tuberculosis_Homo sapiens_hsa05152 | 0.44130714 |
88 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43501528 |
89 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.39256309 |
90 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.38523219 |
91 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.38501485 |
92 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.38469133 |
93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.37978766 |
94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.37807215 |
95 | Peroxisome_Homo sapiens_hsa04146 | 0.36571763 |
96 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.34309202 |
97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34271890 |
98 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.33928667 |
99 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33751607 |
100 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33693209 |